Skip to content

The diagnostic value of metagenomic next-generation sequencing in intestinal tuberculosis

The diagnostic value of metagenomic next-generation sequencing in intestinal tuberculosis

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088403
Enrollment
Unknown
Registered
2024-08-19
Start date
2020-11-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal tuberculosis

Interventions

Gold Standard:In this study, the clinical diagnostic criteria of ITB was the treatment effect after 8 weeks of anti-tuberculosis treatment. If the treatment effect was defined as intestinal tuberculos

Sponsors

Sir Run Run Shaw Hospital, College of Medicine Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. =18 years old. 2. Tuberculin test (T-SPOT) positive. 3. The following three characteristics should be met: a) involvement of ileocecal region; b) the lesions were mainly annular ulcers or the ileocecal valve was fixed and open; c) The main lesion was located from the right hemicolon to the terminal ileum. 4. voluntarily participated in this study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Women are breastfeeding or planning to become pregnant. 2. Patients who did not undergo follow-up colonoscopy. 3. Vulnerable groups, including people with mental illness, cognitive impairment, critically ill patients, minors, pregnant women, illiterate, etc.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;

Countries

China

Contacts

Public ContactYe Lingna

Sir Run Run Shaw Hospital, College of Medicine Zhejiang University

13777429719@163.com+86 137 7742 9719

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026